Boston Scientific Corp (BSX)
83.62
-0.40
(-0.48%)
USD |
NYSE |
Nov 01, 16:00
83.63
+0.01
(+0.01%)
After-Hours: 20:00
Boston Scientific Enterprise Value: 131.03B for Nov. 1, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 01, 2024 | 131.03B |
| October 31, 2024 | 131.62B |
| October 30, 2024 | 131.58B |
| October 29, 2024 | 132.42B |
| October 28, 2024 | 132.71B |
| October 25, 2024 | 132.67B |
| October 24, 2024 | 133.21B |
| October 23, 2024 | 136.67B |
| October 22, 2024 | 137.50B |
| October 21, 2024 | 137.56B |
| October 18, 2024 | 137.59B |
| October 17, 2024 | 135.16B |
| October 16, 2024 | 136.01B |
| October 15, 2024 | 135.67B |
| October 14, 2024 | 136.82B |
| October 11, 2024 | 136.16B |
| October 10, 2024 | 134.83B |
| October 09, 2024 | 135.57B |
| October 08, 2024 | 134.30B |
| October 07, 2024 | 132.20B |
| October 04, 2024 | 132.39B |
| October 03, 2024 | 131.33B |
| October 02, 2024 | 132.31B |
| October 01, 2024 | 131.80B |
| September 30, 2024 | 131.30B |
| Date | Value |
|---|---|
| September 27, 2024 | 130.64B |
| September 26, 2024 | 130.24B |
| September 25, 2024 | 130.86B |
| September 24, 2024 | 130.87B |
| September 23, 2024 | 131.59B |
| September 20, 2024 | 131.47B |
| September 19, 2024 | 131.17B |
| September 18, 2024 | 129.49B |
| September 17, 2024 | 129.41B |
| September 16, 2024 | 130.87B |
| September 13, 2024 | 130.58B |
| September 12, 2024 | 131.34B |
| September 11, 2024 | 130.03B |
| September 10, 2024 | 130.21B |
| September 09, 2024 | 129.60B |
| September 06, 2024 | 128.06B |
| September 05, 2024 | 127.72B |
| September 04, 2024 | 128.59B |
| September 03, 2024 | 127.38B |
| August 30, 2024 | 128.34B |
| August 29, 2024 | 126.69B |
| August 28, 2024 | 125.00B |
| August 27, 2024 | 125.45B |
| August 26, 2024 | 124.92B |
| August 23, 2024 | 124.48B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
45.92B
Minimum
Mar 23 2020
137.59B
Maximum
Oct 18 2024
77.71B
Average
69.70B
Median
Aug 20 2021
Enterprise Value Benchmarks
| Abbott Laboratories | 213.13B |
| Baxter International Inc | 29.17B |
| Haemonetics Corp | 4.537B |
| ResMed Inc | 36.11B |
| Masimo Corp | 8.324B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 468.00M |
| Revenue (Quarterly) | 4.209B |
| Total Expenses (Quarterly) | 3.491B |
| EPS Diluted (Quarterly) | 0.32 |
| Gross Profit Margin (Quarterly) | 68.71% |
| Profit Margin (Quarterly) | 11.12% |
| Earnings Yield | 1.45% |
| Operating Earnings Yield | 2.28% |
| Normalized Earnings Yield | 1.731 |